Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Ella Pickover

Menopausal women who can’t take HRT to be offered new pill to tackle symptoms

Nice said fezolinetant can meaningfully reduce symptoms -

A new daily tablet designed to alleviate hot flushes and night sweats could offer a significant breakthrough for around 500,000 menopausal women, health officials have indicated.

The non-hormonal treatment, known as Fezolinetant (or Veoza), has been approved by the National Institute for Health and Care Excellence (NICE) for prescription on the NHS. It is specifically intended for individuals for whom traditional hormone replacement therapy (HRT) is unsuitable.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.